ID   SBOT-3.1
AC   CVCL_E269
SY   SBOT 3.1; SBOT-3_1
DR   Cosmic; 1149705
DR   Wikidata; Q54952217
RX   PubMed=18217967;
RX   PubMed=18678400;
CC   From: Canadian Ovarian Tissue Bank, University of British Columbia; Vancouver; Canada.
CC   Doubling time: 4-6 days (PubMed=18217967).
CC   Karyotypic information: 51,XX,+8,+12,+14,+14,t(15;16)(q25;p11),+16,+18,+20 (PubMed=18217967).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
DI   NCIt; C5226; Borderline ovarian serous tumor
DI   ORDO; Orphanet_398934; Malignant epithelial tumor of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
RX   PubMed=18217967; DOI=10.1111/j.1525-1438.2007.01171.x;
RA   Woo M.M.M., Salamanca C.M., Miller M., Symowicz J.E., Leung P.C.K.,
RA   Oliveira C., Ehlen T.G., Gilks C.B., Huntsman D., Auersperg N.;
RT   "Serous borderline ovarian tumors in long-term culture: phenotypic and
RT   genotypic distinction from invasive ovarian carcinomas.";
RL   Int. J. Gynecol. Cancer 18:1234-1247(2008).
//
RX   PubMed=18678400; DOI=10.1016/j.ygyno.2008.06.021;
RA   Woo M.M.M., Salamanca C.M., Symowicz J.E., Stack M.S., Miller D.M.,
RA   Leung P.C.K., Gilks C.B., Auersperg N.;
RT   "SV40 early genes induce neoplastic properties in serous borderline
RT   ovarian tumor cells.";
RL   Gynecol. Oncol. 111:125-131(2008).
//